These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 22790535)

  • 1. United States Centers for Disease Control and Prevention issue updated guidance for tackling carbapenem-resistant enterobacteriaceae.
    Kallen A; Guh A
    Euro Surveill; 2012 Jun; 17(26):. PubMed ID: 22790535
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbapenem-resistant Enterobacteriaceae: a growing threat.
    Nursing; 2013 Jul; 43(7):65. PubMed ID: 23778218
    [No Abstract]   [Full Text] [Related]  

  • 3. Beware of nightmare bacteria.
    Nurse Educ; 2013; 38(4):146. PubMed ID: 23778041
    [No Abstract]   [Full Text] [Related]  

  • 4. The emerging threat from carbapenem-resistant enterobacteriaceae.
    Landry J; Hurst H
    Nurs Womens Health; 2013 Dec; 17(6):519-24. PubMed ID: 24589052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measuring Carbapenem-Resistant Enterobacteriaceae in the United States: A Critical Step for Control.
    Hayden MK
    JAMA; 2015 Oct; 314(14):1455-6. PubMed ID: 26436518
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbapenem-resistant Enterobacteriaceae: a potential threat.
    Schwaber MJ; Carmeli Y
    JAMA; 2008 Dec; 300(24):2911-3. PubMed ID: 19109119
    [No Abstract]   [Full Text] [Related]  

  • 7. Carbapenem-resistant Enterobacteriaceae: what has happened, and what is being done.
    Murray PR
    MLO Med Lab Obs; 2013 May; 45(5):26, 28, 30. PubMed ID: 23763046
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of carbapenem-resistant Enterobacteriaceae isolates in the Moroccan community.
    Barguigua A; El Otmani F; Talmi M; Zerouali K; Timinouni M
    Diagn Microbiol Infect Dis; 2012 Jul; 73(3):290-1. PubMed ID: 22521054
    [No Abstract]   [Full Text] [Related]  

  • 9. Carbapenem-resistant enterobacteriaceae: an emerging problem in children.
    Logan LK
    Clin Infect Dis; 2012 Sep; 55(6):852-9. PubMed ID: 22700827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Editorial commentary: imminent challenges: carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancy.
    Johnson K; Boucher HW
    Clin Infect Dis; 2014 May; 58(9):1284-6. PubMed ID: 24463279
    [No Abstract]   [Full Text] [Related]  

  • 11. Retrospective case series of infections caused by carbapenem-resistant Enterobacteriaceae at a tertiary care centre in Lebanon.
    Kanafani ZA; Kmeid J; Nawar T; Assaf SM; Zahreddine N; Kanj SS
    Int J Antimicrob Agents; 2016 May; 47(5):415-6. PubMed ID: 27155945
    [No Abstract]   [Full Text] [Related]  

  • 12. Molecular surveillance and prevalence of carbapenem-resistant Enterobacteriaceae in Northern Taiwan.
    Hsieh WS; Wang NY; Feng JA; Weng LC; Wu HH
    J Antimicrob Chemother; 2014 Oct; 69(10):2871-3. PubMed ID: 25140578
    [No Abstract]   [Full Text] [Related]  

  • 13. The carbapenem-resistant Enterobacteriaceae score: a bedside score to rule out infection with carbapenem-resistant Enterobacteriaceae among hospitalized patients.
    Martin ET; Tansek R; Collins V; Hayakawa K; Abreu-Lanfranco O; Chopra T; Lephart PR; Pogue JM; Kaye KS; Marchaim D
    Am J Infect Control; 2013 Feb; 41(2):180-2. PubMed ID: 22939417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.
    Schwaber MJ; Carmeli Y
    Clin Infect Dis; 2014 Mar; 58(5):697-703. PubMed ID: 24304707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fosfomycin activity versus carbapenem-resistant Enterobacteriaceae and vancomycin-resistant Enterococcus, Detroit, 2008-10.
    Pogue JM; Marchaim D; Abreu-Lanfranco O; Sunkara B; Mynatt RP; Zhao JJ; Bheemreddy S; Hayakawa K; Martin ET; Dhar S; Kaye KS; Lephart PR
    J Antibiot (Tokyo); 2013 Oct; 66(10):625-7. PubMed ID: 23715037
    [No Abstract]   [Full Text] [Related]  

  • 16. The spread of carbapenem-resistant Enterobacteriaceae in South Africa: risk factors for acquisition and prevention.
    Brink A; Coetzee J; Clay C; Corcoran C; van Greune J; Deetlefs JD; Nutt L; Feldman C; Richards G; Nordmann P; Poirel L
    S Afr Med J; 2012 May; 102(7):599-601. PubMed ID: 22748433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing prevalence of carbapenem-resistant Enterobacteriaceae and strategies to avert a looming crisis.
    Watkins RR; Bonomo RA
    Expert Rev Anti Infect Ther; 2013 Jun; 11(6):543-5. PubMed ID: 23750724
    [No Abstract]   [Full Text] [Related]  

  • 18. Carbapenem-resistant Enterobacteriaceae: a call for cultural change.
    Palmore TN; Henderson DK
    Ann Intern Med; 2014 Apr; 160(8):567-9. PubMed ID: 24733200
    [No Abstract]   [Full Text] [Related]  

  • 19. Emerging trends in epidemiology and management of infections caused by carbapenem-resistant Enterobacteriaceae.
    Martirosov DM; Lodise TP
    Diagn Microbiol Infect Dis; 2016 Jun; 85(2):266-75. PubMed ID: 27033631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Delays between Clinical and Laboratory Standards Institute and Food and Drug Administration Revisions of Interpretive Criteria for Carbapenem-Resistant Enterobacteriaceae.
    Bartsch SM; Huang SS; Wong KF; Slayton RB; McKinnell JA; Sahm DF; Kazmierczak K; Mueller LE; Jernigan JA; Lee BY
    J Clin Microbiol; 2016 Nov; 54(11):2757-2762. PubMed ID: 27582516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.